Search
Now showing items 1-6 of 6
Cross-national analysis of estimated narcotic utilization for twelve Arabic speaking countries in the Middle East
(
Elsevier
, 2016 , Article)
Background: Access to narcotics has been described as suboptimal in the Middle East. The objectives of this study were to characterize estimated narcotic use in twelve Arabic-speaking nations and compare across world ...
Interprofessional education in the Arabic-speaking Middle East: Perspectives of pharmacy academics
(
Taylor & Francis
, 2016 , Article)
The current status of interprofessional education (IPE) in Arabic Middle Eastern countries is largely unexamined and there is a need to assess IPE and collaborative practice in these countries. As faculty attitudes towards ...
Medication risk communication with cancer patients in a Middle East cancer care setting
(
Dove Press
, 2016 , Article)
Purpose: Cancer treatments are frequently associated with adverse effects, but there may be a cultural reluctance by care providers to be forthcoming with patients regarding these risks for fear of promoting nonadherence. ...
The impact of genetic and non-genetic factors on warfarin dose prediction in MENA region: A systematic review
(
Public Library of Science
, 2016 , Article Review)
Background Warfarin is the most commonly used oral anticoagulant for the treatment and prevention of thromboembolic disorders. Pharmacogenomics studies have shown that variants in CYP2C9 and VKORC1 genes are strongly and ...
The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes
(
Blackwell Publishing Ltd
, 2016 , Article)
Summary
What is known and objective
Optimal outpatient anticoagulation management requires a systematic and coordinated approach. Extensive evidence regarding the benefits of pharmacist-managed anticoagulation services ...
Medication Risks Communication in Middle East Cancer Patients
(
Hamad bin Khalifa University Press (HBKU Press)
, 2016 , Conference Paper)
Background: Cancer treatments are frequently associated with adverse effects, but there may be a cultural reluctance by care providers to be forthcoming with patients regarding these risks for fear of promoting non-adherence. ...